Rapamycin reduces rejection in heart transplant recipients
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 33 (7-8) , 3221-3222
- https://doi.org/10.1016/s0041-1345(01)02370-3
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTSTransplantation, 2001
- Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre studyThe Lancet, 2000
- USE OF ANTI-CD25 MONOCLONAL ANTIBODY IN COMBINATION WITH RAPAMYCIN TO ELIMINATE CYCLOSPORINE TREATMENT DURING THE INDUCTION PHASE OF IMMUNOSUPPRESSION1Transplantation, 1999